NeuroSense Therapeutics Ltd. Stock Analysis & AI Score
NeuroSense Therapeutics Ltd. (NRSN) has an ST Score of 34.0 (C-), driven by its Valuation (B+) and held back by its Growth (D-). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
NeuroSense Therapeutics Ltd. (NRSN) has an ST Score of 34.0 (C-), driven by its Valuation (B+) and held back by its Growth (D-). Analysts rate it Buy.
- Strongest
- ValuationB+
- Weakest
- GrowthD-
All factor grades
- ValuationB+
- ProfitabilityB
- Financial StrengthC-
- MomentumD+
- GrowthD-
- Piotroski1/9
Contact
NRSN stock: frequently asked questions
What is NRSN's ST Score?
NeuroSense Therapeutics Ltd. (NRSN) has an ST Score of 34.0 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is NRSN a buy, hold, or sell?
Analysts rate NRSN a Buy. Our ST Score grades it C- (34.0/100). The ST Score is a data-driven signal, not a recommendation.
What are NRSN's factor grades?
Valuation B+, Profitability B, Financial Strength C-, Momentum D+, Growth D-.
What is NRSN's valuation grade?
NeuroSense Therapeutics Ltd. (NRSN) earns a valuation grade of B+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is NRSN's growth grade?
NeuroSense Therapeutics Ltd. (NRSN) earns a growth grade of D-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is NRSN's profitability grade?
NeuroSense Therapeutics Ltd. (NRSN) earns a profitability grade of B, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is NRSN's financial strength grade?
NeuroSense Therapeutics Ltd. (NRSN) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is NRSN's Piotroski score?
NeuroSense Therapeutics Ltd. (NRSN) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.